BOLT vs DVA · rev $7.7M vs P/E 14, rev $12.82B
Bolt Biotherapeutics (BOLT) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
BOLT currently screens at market cap $11.3M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the BOLT and DVA stock pages for the full models.
Not investment advice.